Advertisement

Topics

Eli Lilly and Company Company Profile

10:50 EDT 23rd July 2017 | BioPortfolio

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat <!--LGfEGNT2Lhm-->depression, <!--LGfEGNT2Lhm-->schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. We are committed to providing answers that matter - through medicines and information - for some of the world's most urgent medical needs.

Products for Human Use (published 14th May 2013)

BONE MUSCLE JOINT
Evista® (raloxifene hydrochloride)
Forteo® (teriparatide [rDNA origin] injection)
CARDIOVASCULAR
Adcirca® (tadalafil)
Effient® (prasugrel)
Livalo® (pitavastatin)
DIABETES
Glucagon™ (glucagon for injection [rDNA origin])
Humalog® (insulin lispro injection USP [rDNA origin])
Humalog® Mix50/50™ (50% Insulin lispro protamine suspension, 50% insulin lispro injection [rDNA origin])
Humalog® Mix75/25™ (75% Insulin lispro protamine suspension, 25% insulin lispro injection [rDNA origin])
Humulin® R (U-100) ) (regular insulin human injection, USP [rDNA origin])
Humulin® R (U-500) (regular U-500 [concentrated] insulin human injection, USP [rDNA origin])
Humulin® 70/30 (70 percent human insulin isophane suspension, 30 percent human insulin injection [rDNA origin])
Humulin® N (NPH human insulin [rDNA origin] isophane suspension)
Tradjenta® (linagliptin) tablets**
ENDOCRINE
Humatrope® (somatropin [rDNA origin] for injection)
MEN'S HEALTH
Axiron® (testosterone)
Cialis® (tadalafil)
NEUROSCIENCE
Amyvid™ (Florbetapir F 18 Injection)
Cymbalta® (duloxetine delayed release)
Strattera® (atomoxetine hydrochloride)
Zyprexa®Relprevv™  (olanzapine)
ONCOLOGY
Alimta® (pemetrexed for injection)
Erbitux® (cetuximab)

ANIMAL USE

ELANCO COMPANION ANIMAL HEALTH
Assurity ®
Comfortis ®
Reconcile ®
Trifexis ®

ELANCO FOOD SOLUTIONS
Coban ®
Component ®
Component wiTh Tylan Implants ®
Elector Bait ®
Elector PSP ®
HeifermaX 500 ®
Keto-Test ®
Long-Acting Implants ®
Maxiban ®
Micotil ®
Monteban ®
Optaflexx ®
Paylean ®
Posilac ®
Pulmotil ®
Rumensin ®
StandGuard Pour-On ®
StanGuard Premise ®
Topmax ®
Tylan ®
Tylan Injection ®
Tylan Soluble ®
Tylan Sulfa-G ®

Lilly(TM) is a registered trademark of Eli Lilly and Company.  BioPortfolio's use of the Lilly(TM) trademark on this site does not imply any affiliation with or endorsement by Eli Lilly and Company.  If you are looking for Eli Lilly and Company's official website, please visit www.lilly.com.

Location

Lilly Corporate Center
Indianapolis
Indiana
46285
United States of America

Contact

Phone: +1-317-276-2000
Fax: 317 276 2095


News Articles [658 Associated News Articles listed on BioPortfolio]

Lilly Declares Third-Quarter 2017 Dividend

INDIANAPOLIS, June 19, 2017 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2017 of $0.52 per share on outstanding common s...

Lilly Declares Second-Quarter 2017 Dividend

INDIANAPOLIS, May 1, 2017 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2017 of $0.52 per share on outstanding common st...

Lilly to Participate in UBS Global Healthcare Conference

INDIANAPOLIS, May 3, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the UBS Global Healthcare Conference on Tuesday, May 23, 2017. Derica Rice, Lilly's executive vice presiden...

Lilly Confirms Date and Conference Call for Second-Quarter 2017 Financial Results Announcement

INDIANAPOLIS, July 6, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the second quarter of 2017 on Tuesday, July 25, 2017. Lilly will also conduct a con...

Lilly Confirms Date and Conference Call for First-Quarter 2017 Financial Results Announcement

INDIANAPOLIS, April 11, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2017 on Tuesday, April 25, 2017. Lilly will also conduct a c...

Eli Lilly opens expanded biotechnology center in San Diego

Eli Lilly and Company has announced completion of a $90 million expansion of its Biotechnology Center in San Diego, California. Lilly's new space will help foster and accelerate the discovery of medic...

Eli Lilly appoints Leigh Ann Pusey as senior VP of corporate affairs and communications

Eli Lilly and Company, announced that Leigh Ann Pusey will be joining Lilly as senior vice president of corporate affairs and communications, effective June 12, 2017. She will be a member of Lilly's e...

Lilly Announces Webcast to Discuss Oncology Pipeline

INDIANAPOLIS, May 2, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Saturday, June 3, 2017, to discuss the company's oncology pipeline, including data from the M...

Drugs and Medications [1287 Associated Drugs and Medications listed on BioPortfolio]

Xigris [Eli Lilly and Company]

These highlights do not include all the information needed to use XIGRIS safely and effectively. See full prescribing information for XIGRIS.XIGRIS (drotrecogin alfa (activated)) injection, powder, ly...

Axid ar [Wyeth Consumer Healthcare]

Axid AR (nizatidine)

Qsr hand sanitizer [Kay Chemical Company]

Drug Facts

Conquest [KAY CHEMICAL CO.]

Drug Facts

Actigel [Kay Chemical Company]

Drug Facts

Clinical Trials [82 Associated Clinical Trials listed on BioPortfolio]

An Open Label Study of Oral Enzastaurin in Patients With Cancer

This study will collect further basic safety data on patients with cancer treated with enzastaurin. This study is not open to the public. The purpose of the this study is to extend the c...

Safety and Efficacy of G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

This is a blinded, randomized crossover study to compare the safety and efficacy of G-Pen™ (glucagon injection) to Lilly Glucagon (glucagon for injection [rDNA origin]) for hypoglycemia ...

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Disorder Mania

Inpatient Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Mania: This study recruits adult subjects who are diagnosed with Bip...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Companies [1406 Associated Companies listed on BioPortfolio]

Lilly USA

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and fro...

Eli Lilly and Company

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that...

Lilly Corporate Center

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. ...

Applied Molecular Evolution

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME...

Eli Lilly and Company Limited

More Information about "Eli Lilly and Company" on BioPortfolio

We have published hundreds of Eli Lilly and Company news stories on BioPortfolio along with dozens of Eli Lilly and Company Clinical Trials and PubMed Articles about Eli Lilly and Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eli Lilly and Company Companies in our database. You can also find out about relevant Eli Lilly and Company Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Bipolar Disorders
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Over half of Bipolar cases develops before the age of 25. Bipolar ...

Schizophrenia
Schizophrenia is a common  serious long-term mental health condition that affects 5 in 1000 in the UK. It causes a range of different psychological symptoms; hallucinations, delusions, muddled thoughts based on the hallucinations or delusions and ch...


Corporate Database Quicklinks



Searches Linking to this Company Record